Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: jbershad who wrote (618)	5/12/1998 9:05:00 PM
From: Luke	Read Replies (3) \| Respond to of 3202

Are you thinking about the ESTs? whether ESTs will be allowed by the US PTO, and what scope they will be given by the courts later on?

To: jbershad who wrote (618)	5/12/1998 9:07:00 PM
From: Rocketman	Read Replies (1) \| Respond to of 3202

Word is that for several years now the Patent office has a special room dedicated to holding INCY filings. The EST filings are huge. Some time back the PTO was complaining about how the fees charged don't come near covering the costs of processing these patent applications. INCY has had an in-house patent group in excess of 20 people since at least 1995. In short, yes they have patents, they have applications and they will ultimately defend them. Per INCY CEO Roy Whitfield at the 1997 annual meeting: <<<<<< 28 US patents issued, and one of, if not the largest genomic patent platforms. >>>>>> They know how to play the game. Rman